Report Thumbnail
Product Code IW091271244H74
Published Date 2021/6/1
English143 PagesAsia Pacific

ASIA-PACIFIC OXYGENATORS MARKET FORECAST 2021-2028Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code IW091271244H74◆The Jun 2025 edition is also likely available. We will check with the publisher immediately.
Published Date 2021/6/1
English 143 PagesAsia Pacific

ASIA-PACIFIC OXYGENATORS MARKET FORECAST 2021-2028Pharmaceutical_LifeSciense Market



Abstract


Summary

KEY FINDINGS The Asia-Pacific oxygenators market is estimated to develop with a CAGR of 5.80% during the forecasting period of 2021 to 2028. The increasing prevalence of chronic diseases such as cardiopulmonary conditions due to unhealthy eating habits and excessive tobacco consumption, the increasing awareness about oxygenators, and the extensive population base with low per capita income, are among the key factors accredited to the region’s market growth. MARKET INSIGHTS The Asia-Pacific oxygenators market growth assessment includes the analysis of South Korea, India, Japan, India, Thailand, Australia & New Zealand, Vietnam, China, and the rest of the Asia-Pacific. The increasing burden of target diseases predominantly drives the market growth in India. According to a report published in 2019 by Prabha Desikan et al., in “Circulation: Cardiovascular Quality and Outcomes,” cardiovascular diseases were the major cause of death in the country. The epidemiological transition was essentially attributed to the increasing prevalence of cardiovascular diseases and their risk factors across India. While 1 in 4 deaths in the country was due to cardiovascular illnesses, stroke and ischemic heart disease were responsible for over 80% of the burden. Conversely, the COVID-19 pandemic has significantly raised the adoption of ECMO procedures in South Korea, thereby fueling the market for oxygenators in the country. The nation also observes an increasing incidence of respiratory ailments such as chronic obstructive pulmonary disease (COPD), with a 13% prevalence reported in people over the age of 40, as per the 2018 study published in Synapse KoreaMed. Thus, the abovementioned factors are expected to drive the market growth in the Asia-Pacific during the forecast years. COMPETITIVE INSIGHTS Leading firms operating in the market are Terumo Corporation, MicroPort Scientific Corporation, Nipro Corporation, Senko Medical Instrument MFG Co Ltd, etc. Our report offerings include: • Explore key findings of the overall market • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges) • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions • Market Segmentation cater to a thorough assessment of key segments with their market estimations • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc. • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc. • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Table of Contents

  • 1 RESEARCH SCOPE & METHODOLOGY

    • 1.1 STUDY OBJECTIVES
    • 1.2 SCOPE OF STUDY
    • 1.3 METHODOLOGY
    • 1.4 ASSUMPTIONS & LIMITATIONS
  • 2 EXECUTIVE SUMMARY

    • 2.1 MARKET SIZE & ESTIMATES
    • 2.2 MARKET OVERVIEW
  • 3 MARKET DYNAMICS

    • 3.1 KEY DRIVERS
      • 3.1.1 PREVALENCE OF AGING POPULATION
      • 3.1.2 INCIDENCE OF VARIOUS CARDIOPULMONARY DISEASES
      • 3.1.3 ADVANCEMENTS IN TECHNOLOGY
      • 3.1.4 GROWING HEALTHCARE EXPENDITURE
    • 3.2 KEY RESTRAINTS
      • 3.2.1 RISK OF MORBIDITY AND SEVERE COMPLICATIONS
      • 3.2.2 STRINGENT REGULATIONS
      • 3.2.3 PRESENCE OF ALTERNATIVE TO OXYGENATORS
  • 4 KEY ANALYTICS

    • 4.1 IMPACT OF COVID-19 ON OXYGENATORS MARKET
    • 4.2 KEY MARKET TRENDS
    • 4.3 PORTER’S FIVE FORCES ANALYSIS
      • 4.3.1 BUYERS POWER
      • 4.3.2 SUPPLIERS POWER
      • 4.3.3 SUBSTITUTION
      • 4.3.4 NEW ENTRY
      • 4.3.5 INDUSTRY RIVALRY
    • 4.4 OPPORTUNITY MATRIX
    • 4.5 VENDOR LANDSCAPE
  • 5 MARKET BY PRODUCT TYPE

    • 5.1 MEMBRANE OXYGENATORS
    • 5.2 BUBBLE OXYGENATORS
  • 6 MARKET BY APPLICATION

    • 6.1 RESPIRATORY
    • 6.2 CARDIAC
    • 6.3 EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)
  • 7 GEOGRAPHICAL ANALYSIS

    • 7.1 ASIA-PACIFIC
      • 7.1.1 MARKET SIZE & ESTIMATES
      • 7.1.2 KEY GROWTH ENABLERS
      • 7.1.3 KEY CHALLENGE
      • 7.1.4 KEY PLAYERS
      • 7.1.5 COUNTRY ANALYSIS
        • 7.1.5.1 CHINA
        • 7.1.5.2 JAPAN
        • 7.1.5.3 INDIA
        • 7.1.5.4 AUSTRALIA & NEW ZEALAND
        • 7.1.5.5 SOUTH KOREA
        • 7.1.5.6 THAILAND
        • 7.1.5.7 INDONESIA
        • 7.1.5.8 VIETNAM
        • 7.1.5.9 REST OF ASIA-PACIFIC
  • 8 COMPETITIVE LANDSCAPE

    • 8.1 KEY STRATEGIC DEVELOPMENTS
      • 8.1.1 MERGERS & ACQUISITIONS
      • 8.1.2 PRODUCT LAUNCHES & DEVELOPMENTS
      • 8.1.3 PARTNERSHIPS & AGREEMENTS
      • 8.1.4 BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
    • 8.2 COMPANY PROFILES
      • 8.2.1 BRAILE BIOMEDICA
      • 8.2.2 CHALICE MEDICAL LTD
      • 8.2.3 EUROSETS
      • 8.2.4 GEN WORLD MEDICAL DEVICES
      • 8.2.5 GETINGE AB
      • 8.2.6 LIVANOVA PLC
      • 8.2.7 MC3 CARDIOPULMONARY
      • 8.2.8 MEDTRONIC PLC
      • 8.2.9 MICROPORT SCIENTIFIC CORPORATION
      • 8.2.10 NIPRO CORPORATION
      • 8.2.11 ORIGEN BIOMEDICAL INC
      • 8.2.12 OWGELS GROUP
      • 8.2.13 SENKO MEDICAL INSTRUMENT MFG CO LTD (MERA)
      • 8.2.14 TERUMO MEDICAL CORPORATION
      • 8.2.15 XENIOS AG (FRESENIUS MEDICAL COMPANY)
USD 1,600 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.